New Technology Uses Tears to Detect Ocular Disorders, Diabetes

Biomedical engineers at Wenzhou Medical University have developed a system for detecting ocular, endocrine, and even neurodegenerative disorders using just a few tears. The system, aptly named iTEARS, uses exosomes in tears to determine whether a certain disease is present in the human body.

Exosomes themselves act as microscopic messengers that carry information about cell health and various bodily processes. When exosomes are captured and analyzed in sufficient quantities, they have the power to reveal whether a person has specific disorders…but the “quantity” portion of testing is the tough part. Tears are already quite small, and obtaining tear samples with high enough concentrations of exosomes can be challenging.

iTEARS, however, can isolate exosomes from the rest of a solution, allowing the exosomes’ cellular messages to shine through. The technology uses two vibrating nanoporous membranes to separate exosomes from tears in as little as five minutes. Once isolated, the exosomes can be used for various forms of disease testing. Not only can the molecular “fingerprints” within a patient’s exosomes help diagnose dry eye, but they can differentiate between types of the disorder, thus allowing the patient and their provider to determine which treatment would be most effective. Compared with a healthy control, tear exosomes can also be used to detect diabetic retinopathy—a relatively rare eye condition associated with diabetes—and even diabetes itself.

The use of exosomes in detecting certain disorders isn’t new. Exosomes exist in all bodily fluids, including blood and urine, which are frequently used to determine whether a patient has a certain disease or condition. But blood and urine aren’t exactly approachable when it comes to at-home tests, which the engineers at Wenzhou hope to eventually create with iTEARS. If such a product is ever made, those worried about ocular and endocrine disorders can test themselves affordably and in the comfort of their own homes, then seek out a specialist if needed.

Most remarkably, such a test might extend beyond ocular and endocrine disorders. The team at Wenzhou believes their technology might someday be used to detect emotional disorders, cancer, and neurodegenerative disorders. While they didn’t specify which disorders might be diagnosed using iTEARS, it’s become known in recent years that exosomes might play a role in detecting Alzheimer’s disease and Parkinson’s disease.

Continue reading

Review: The Oculus Quest 2 Could Be the Tipping Point for VR Mass Adoption

The Oculus Quest 2 is now available, and it's an improvement over the original in every way that matters. And yet, it's $100 less expensive than the last release. Having spent some time with the Quest 2, I believe we might look back on it as the headset that finally made VR accessible to mainstream consumers.

Facebook Announces a New Oculus VR Feature: In-Game Ads

Facebook will soon build ads into your VR games. The company claims the advertising will benefit developers, but it appears to have something else in mind.

Facebook, Instagram, Oculus, WhatsApp All Offline, Company Communication Crippled [Updated]

Facebook, Instagram, Oculus, and WhatsApp all fell offline earlier today on one of Facebook's worst news days this... week.

Oculus Gives Discontinued Oculus Go a New Lease on Life with Unlocked Software

The release of the Oculus Go in 2018 was an important step for Facebook's Virtual Reality division, but the product was short-lived. After being made obsolete by the Oculus Quest, the company discontinued the Go in 2020. Still, Facebook sold millions of the standalone headsets, and now they're more capable thanks to an unlocked software update.